Anuh Pharma (ANUHPHR)
FAST GROWERFairStock Score: 49/100 — MIXED
Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹81.7 |
| Market Cap | ₹773.33 Cr |
| P/E Ratio | 18.49 |
| ROCE | 17.24% |
| ROE | 13.8% |
| Dividend Yield | 1.94% |
| Profit Growth | 30.08% |
| Debt/Equity | 0 |
| Sales Growth | 23.62% |
| Promoter Holding | 71.82% |
| 52-Week Range | ₹67 — ₹114.83 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹30.09 |
Anuh Pharma trades with a P/E ratio of 18.49, ROCE of 17.24%, ROE of 13.8%, profit growth of 30.08%, debt-to-equity of 0. The FairStock Score of 49/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer